# Medicare

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/medicare-product
Canonical HTML page: https://getbiobrief.com/entity/medicare-product

## Timeline

- **2026-08-27**: Initial Expiration — The first six-month period ends, at which point CMS may choose to extend the moratorium.
- **2026-02-27**: Moratorium Effective — CMS officially publishes the notice and the nationwide enrollment freeze begins immediately.
- **2025-10-31**: Data Review Concludes — CMS finishes a multi-year review of Medicare enrollment and claims data identifying high-risk trends.
- **2025-02-01**: OIG Fraud Warning — HHS OIG highlights billions in improper DME payments over the previous decade.

## Recent coverage (1 stories)

### CMS Imposes Unprecedented Nationwide Moratorium on DMEPOS Enrollments
2026-03-06 01:27:47 · Sentiment: Bearish · Impact: 7/10 · Sources: 2

The Centers for Medicare & Medicaid Services (CMS) has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory move, effective February 27, 2026, aims to curb systemic fraud and billions in improper payments within the DMEPOS sector.
Full story: https://getbiobrief.com/story/cms-nationwide-dmepos-moratorium-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.